Skip to main content
. 2017 Jun 16;83(13):e00337-17. doi: 10.1128/AEM.00337-17

TABLE 2.

Primers used in this work

Primer use Primer name Sequence (5′–3′) Reference
ICE labeling This study
F1-4 CDS7 F GAGATTGAGCATATCCTTCC
F1-4 CDS8 R_Bis GGTGACTAGTTATCTACACGCGAGATTCGTGGACTAACTT
F1-4 CDS9 F_Bis CCATATCCTTCTTTTTCTGCTCACTATCTTGTTCGTTTTGT
F1-4 CDS9 R GGAGAGTTTAGCTGGGAGG
ICE F4-2 fragment I_F GGAAATATCCTGTTGTCATC
ICE F4-2 fragtI_R-catbis GGTGACTAGTTATCTACACGCCTATAAAGTTGTTAAGTTCACT
ICE F4-2 fragtII_F-catbis CCATATCCTTCTTTTTCTGGCGTGTAATTGAAGAGTGA
ICE F4-2 fragment II_R GTCTAAACTGAGCCAAGAAG
Cat_F GCCTCCTAAATTCACTTTAG
Cat_R GTAAAAAGTACAGTCGGCAT
Detection of ICE integrated and excised forms
    attB amplification 23
attBfdaSsal GCCCAACCAAATAACACTAAA
attB ST3 Rev CTCTTCGACCCACGTAAATTC
    attI amplification 23
intST3 For AGGGCTTTCTGACGAATTAG
attI ST3 Rev CGGTGTAATGGGAAGTATGG
    attL amplification
attL Rv CDS gwlG CGGTGTAATGGGAAGTATGG This study
attBfdaSsal GCCCAACCAAATAACACTAAA 23
    attR amplification
intST3 for AGGGCTTTCTGACGAATTAG 23
intICESt3-fdaRev ACCAGGTTTCGATGCTATTACAG 35
    Integrase gene 23
intST3 for AGGGCTTTCTGACGAATTAG
intST3 Rev GAGTTCTAATAACTGAGGCTA
Semiquantitative PCR
    attI amplification This study
intICEF1-4 For AGGTCTTTCTGACGAATTAG
attIICEF1-4 Rev CGGCGTAATGGGAAGTATGG
    attB amplification 23
attBfdaSsal GCCCAACCAAATAACACTAAA
attB ST3 Rev CTCTTCGACCCACGTAAATTC
    fda amplification
Fda1 TTCAAGAATTTACGTGGG This study
Fda2 AGATGCTAAAGCTATGGTTG 56
Donor/recipient discrimination
    ITS16S/23S 24
16SITS TTGTACACACCGCCCGTCA
23SITS GGTACCTTAGATGTTTCAGTTC
    ddlA gene 60
ddlA up TCAAGTGTGGCTATGGA
ddlA dn GTAGATGGCTCCATCCTC
    E. faecalis fda-specific amplification 24
Efa fba1b ATGTGTTCTTCTGCATCTTT
Efa fba2 CCCATTGATTACGATTTTT
    RAPD 56
XD9 GAAGTCGTCC
    pMG36e
pMG36e Fwd GCCTCCTCATCCTCTTCAT 24
pMG36e_R ACAGAACCGTTTCTACTCAATGAAC This study